(News Bulletin 247) – The company experienced a clear acceleration in its momentum in the third quarter, with growth of 12.5% ​​like-for-like. Virbac has increased its revenue growth target for this year.

Virbac on relaunch. While its shares fell over the whole of 2025, the veterinary laboratory’s stock recorded a good session this Friday, October 17.

The price of Virbac thus rose 7% at the end of the day, recording the second largest increase in the SBF 120, behind the impressive increase in Essilorluxottica (+12%). The stock returns to green over the whole of 2025 (+5%).

The group based in the Alpes-Maritimes recorded a very clear acceleration in its growth in the third quarter, with an increase of 12.5% ​​year-on-year, on a comparable basis, after 6.4% in the second quarter and 4.9% in the first. Jefferies likes the publication, calling it “robust.”

The increase in revenues was driven by North America (+48.5% like-for-like), where growth was supported by restocking.

>> Access our exclusive graphic analyses, and gain insight into the Trading Portfolio

Objectives revised upwards

“The third quarter of 2024 was in fact impacted by a destocking, while the current quarter benefits from a significant restocking at one of our distributors,” develops Virbac.

Excluding this effect on inventories, however, revenue growth remains high, at 9.5%. “It was driven by good sales momentum for our specialty and dental products intended for pets,” explains the company.

This strong momentum in the third quarter led the company to raise its growth forecast for 2025, with Virbac counting on a range of 5.5 to 7% on a comparable basis compared to 4 to 6% previously.

The group maintained its current operating margin projection excluding acquisition-related depreciation and amortization at 16%.

Virbac also confirmed that it was counting on a “moderate” impact from American customs duties.

“Approximately two thirds of our American turnover in 2025 and almost 80% by the end of 2026 (due to ongoing industrial projects) should be generated by our local production in the United States,” the company said.

“In addition, purchases by our American subsidiary of components and raw materials outside the United States represent approximately 8 million euros over a full year,” she adds.

“Taking this into account, the direct impact of customs duties (i.e. not taking into account possible price increases which could offset all or part of these impacts), as assessed to date, is around $4 million in a full year,” the group specifies.